Co-proxamol

Grey

Brand Name(s):Distalgesic

Indication:All indications

Rationale:3

Considered:Apr-09

Review Date:Oct-25

Comments:
Co-proxamol has been withdrawn from the market. This decision followed a 12-week consultation exercise by the MHRA to gather further information on the risks and benefits of co-proxamol. Any patients who are still taking co-proxamol should, where possible, be moved to a suitable alternative. A provision will remain for the supply of unlicensed co-proxamol on the responsibility of the prescriber.